Revelation Biosciences, Inc. (NASDAQ:REVBW) Short Interest Up 184.6% in May

Revelation Biosciences, Inc. (NASDAQ:REVBW) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 3,307 shares, an increase of 184.6% from the May 14th total of 1,162 shares. Based on an average daily volume of 80,422 shares, the days-to-cover ratio is presently 0.0 days.

Revelation Biosciences Stock Down 30.2%

Shares of REVBW stock traded down $0.00 on Friday, reaching $0.01. The stock had a trading volume of 26,181 shares, compared to its average volume of 81,885. The firm’s 50-day moving average is $0.01 and its two-hundred day moving average is $0.01. Revelation Biosciences has a 12 month low of $0.01 and a 12 month high of $0.04.

About Revelation Biosciences

Revelation Biosciences, Inc (NASDAQ: REVBW) is a clinical-stage molecular diagnostics company focused on the rapid detection of life-threatening bacterial infections. The company leverages next-generation sequencing (NGS) to analyze cell-free microbial DNA in patient blood samples, with an emphasis on early identification of pathogens in bloodstream infections and hospital-acquired pneumonia. By targeting critically ill patients, Revelation Biosciences aims to shorten time to diagnosis and guide more effective antimicrobial therapy.

The company’s technology platform integrates high-throughput DNA sequencing with proprietary bioinformatics algorithms to differentiate pathogenic microbes from background microbial DNA.